Welcome to Igenomix
Come into the new age of science
Genomic Precision Diagnostics
We offer new services such as the new Precision Genomic Diagnosis division
We have expanded our reproductive health portfolio with this new comprehensive genetic diagnostic service that covers the entire life cycle and is supported by all available technologies (single gene, CMA, etc.) and it has more than 250 different diagnostic panels:
Prenatal genetic diagnosis integral service
- Prenatal Genetic Diagnosis is a service that identifies genetic alterations in the fetus that can lead to a disorder during pregnancy or the neonatal period that is clinically actionable.
- 6-8% of pregnancies are high risk
- 3-5% of pregnancies show ultrasound findings
- 3% of newborns present congenital defects
Endometrial Health
The endometrium matters
- The ERA test offers a personalized transfer recommendation in the first biopsy in 90% of the samples analyzed
- The ERA test analyzes the 248 genes needed to accurately determine the personalized implantation window for each patient
- 71% of patients that had a personalized embryo transfer, had a baby after one year
- The ERA intelligent algorithm based on Artificial Intelligence can detect 12 hour displacements in the window of implantation
- 30% of infertile women have pathogenic bacteria in their endometrium: EMMA & ALICE test for a 360º view of endometrial health
EMBRACE
Embryo Analysis of Culture Environment
- A non-invasive test for prioritizing embryo transfer that avoids invasive embryo biopsy, potentially increasing accessibility for a wider patient population.
- EMBRACE scores embryos according to their probability of being healthy and viable based on chromosomal information.
- The recent identification of embryo cell-free DNA in spent blastocyst media opened a new era of possibilities for non-invasive embryo aneuploidy testing in assisted reproductive technologies.
Yosu Franco, PhD
Laboratory and Scientific Director of Hospital Ruber Internacional, Madrid, Spain
Poster number: P560
Title: Comparative analysis of non-invasive preimplantation genetic testing of aneuploidies (niPGT-A), PGT-A and IVF cycles without aneuploidy testing: preliminary results.
Screening Diagnostics
CGT our advanced Carrier Genetic test, the most complete Genetic screening test based on Exome sequencing that cover over 2,000 genes that cause more than 2,200 diseases, providing in 20 working days the most accurate test results to future parents giving them the opportunity to make informed decisions and review the range of options available to guide pregnancy and family planning.
Why choose our CS Exome Based?
CLINICAL ADVANTAGE
- Allows for testing of All known recessive conditions.
- Increases the overall detection rate minimizing the global residual risk.
MATCHING
- Matching possible with ALL genetic lab tests in the market.
- Simplifies competitor CS panel mirroring as no resequencing is required to provide matching information.
UPGRADES
- Any upgrade possible at a later date if required
REANALYSIS
- Exome Sequencing offers added value for future analysis of a given patient.
- Provides analytical possibilities in an adverse event of a newborn with a genetic condition.
Newborn Screening
Comprehensive genetic test
Newborn Screening Test (NBS) is a comprehensive genetic test that includes 104 genes analyzed using Next Generation Sequencing (NGS) technologies allowing a direct approach of genetic disorders to reach an accurate diagnosis. It is a screening test of genetic actionable diseases indicated for all newborns and performed during the first days of life.
- Diseases with high prevalence rates.
- Detect diseases where you can take action to improve prognosis.
- Genes selected according to evidence-based medicine.
- Availability and access to treatment.
Clinic Portal
Connecting clinics, specialists, and patients through our digital ecosystem
In Igenomix we want to contribute by making doctor’s daily lives easier. With this idea in mind, we have developed a new Clinic Portal where specialists can manage everything which is necessary to request genetic tests, obtain documentation, request kits and even receive and download their patient’s results. Ask your local delegate for additional information!
